Quantitative analysis of the novel anticancer drug ABT-518, a matrix metalloproteinase inhibitor, plus the screening of six metabolites in human plasma using high-performance liquid chromatography coupled with electrospray tandem mass spectrometry (Q44811526)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quantitative analysis of the novel anticancer drug ABT-518, a matrix metalloproteinase inhibitor, plus the screening of six metabolites in human plasma using high-performance liquid chromatography coupled with electrospray tandem mass spectrometry |
scientific article published in March 2004 |
Statements
1 reference
Quantitative analysis of the novel anticancer drug ABT-518, a matrix metalloproteinase inhibitor, plus the screening of six metabolites in human plasma using high-performance liquid chromatography coupled with electrospray tandem mass spectrometry (English)
1 reference
1 reference
Stokvis E
1 reference
Rosing H
1 reference
Crul M
1 reference
Rieser MJ
1 reference
Schellens JH
1 reference
Beijnen JH
1 reference
1 March 2004
1 reference
1 reference
Identifiers
1 reference